Cite
HARVARD Citation
Kappos, L. et al. (2021). Safety and efficacy of daclizumab beta in patients with relapsing multiple sclerosis in a 5-year open-label study (EXTEND): final results following early termination. Therapeutic advances in neurological disorders. p. . [Online].